ImmPACT Bio USA Inc.

About ImmPACT Bio USA

ImmPACT Bio USA is a private company based in West Hills, California, incorporated in 2019 in Delaware. It has reported $139,855,923 raised in one offering on Form D since January 2022. Its chief executive is Sumant Ramachandra.

Funding Rounds (SEC Form D)

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ImmPACT Bio USA's Form D filed Apr 2, 2024.

YC

Yvonne Chen

Director

Erez Chimovits

Director

Also a director at ADARx Pharmaceuticals and Capstan Therapeutics, a senior managing director at orbimed at Fore Biotherapeutics and an executive officer at OrbiMed Partners.

HL

Han Lee

Executive officer

MS

Michal Silverberg

Director

XC

Xiangmin Cui

Director

Also a director at Baylor Genetics, LevitasBio and SunnyBay BioTech and an executive officer, director and promoter at Decheng Capital Global Life.

SG

Sheila Guirathi

Director

SR

Sumant Ramachandra

President and Chief Executive Officer, director

YY

Yvonne Yamanaka

Director

CX

Cindy Xiong

Director

Earlier filings also listed Robbie Woodman (director, last listed Aug 2020), Richard Kendall (president and chief executive officer, director, last listed Aug 2020), David Zigdon (director, last listed Aug 2020), Assaf Keret (director, last listed Aug 2020) and Asish Xavier (director, last listed Aug 2020).

Largest Form D Raises Filed the Same Day

Private companies with new Form D filings accepted by the SEC on Apr 2, 2024.

Sources

1. SECImmPACT Bio USA Inc. Form D, filed Jan 20, 2022
2. SECImmPACT Bio USA Inc. filing history